Cudarolimab

Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
Read more
€0.00 (tax incl.)
Reference:
HY-P99836
Product Details
HY-P99836

Data sheet

Size
Multiple sizes
Reactivity
Orexin Receptor (OX Receptor)
Application
COVID-19-immunoregulation
CAS
2244739-29-3

Menu

Settings